BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Prognosis
19 results:

  • 1. Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro.
    Cao Q; Hajosch A; Kast RE; Loehmann C; Hlavac M; Fischer-Posovszky P; Strobel H; Westhoff MA; Siegelin MD; Wirtz CR; Halatsch ME; Karpel-Massler G
    Br J Cancer; 2024 May; 130(8):1365-1376. PubMed ID: 38396172
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse.
    Rusconi C; Cheah CY; Eyre TA; Tucker D; Klener P; Giné E; Crucitti L; Muzi C; Iadecola S; Infante G; Bernard S; Auer RL; Pagani C; Duglosz-Danecka M; Mocikova H; van Meerten T; Cencini E; Marin-Niebla A; Williams ME; Angelillo P; Nicoli P; Arcari A; Morello L; Mannina D; Vitagliano O; Sartori R; Chiappella A; Sciarra R; Stefani PM; Dreyling M; Seymour JF; Visco C
    Blood; 2022 Oct; 140(17):1907-1916. PubMed ID: 35789260
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics.
    Koessinger AL; Cloix C; Koessinger D; Heiland DH; Bock FJ; Strathdee K; Kinch K; Martínez-Escardó L; Paul NR; Nixon C; Malviya G; Jackson MR; Campbell KJ; Stevenson K; Davis S; Elmasry Y; Ahmed A; O'Prey J; Ichim G; Schnell O; Stewart W; Blyth K; Ryan KM; Chalmers AJ; Norman JC; Tait SWG
    Cell Death Differ; 2022 Oct; 29(10):2089-2104. PubMed ID: 35473984
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Aspirin Induced Glioma Apoptosis through Noxa Upregulation.
    Chang CY; Pan PH; Li JR; Ou YC; Wang JD; Liao SL; Chen WY; Wang WY; Chen CJ
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545774
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history.
    Meiser B; Quinn VF; Mitchell G; Tucker K; Watts KJ; Rahman B; Peate M; Saunders C; Geelhoed E; Gleeson M; Barlow-Stewart K; Field M; Harris M; Antill YC; Susman R; Bowen MT; Mills L; Kirk J;
    Eur J Hum Genet; 2018 Jul; 26(7):972-983. PubMed ID: 29599518
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Targeting intrinsic apoptosis and other forms of cell death by BH3-mimetics in glioblastoma.
    Karpel-Massler G; Ishida CT; Zhang Y; Halatsch ME; Westhoff MA; Siegelin MD
    Expert Opin Drug Discov; 2017 Oct; 12(10):1031-1040. PubMed ID: 28712306
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications.
    Bashari MH; Fan F; Vallet S; Sattler M; Arn M; Luckner-Minden C; Schulze-Bergkamen H; Zörnig I; Marme F; Schneeweiss A; Cardone MH; Opferman JT; Jäger D; Podar K
    Breast Cancer Res; 2016 Feb; 18(1):26. PubMed ID: 26921175
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. TIC10/ONC201 synergizes with Bcl-2/Bcl-xL inhibition in glioblastoma by suppression of mcl-1 and its binding partners in vitro and in vivo.
    Karpel-Massler G; Bâ M; Shu C; Halatsch ME; Westhoff MA; Bruce JN; Canoll P; Siegelin MD
    Oncotarget; 2015 Nov; 6(34):36456-71. PubMed ID: 26474387
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Activity of ibrutinib in mantle cell lymphoma patients with central nervous system relapse.
    Bernard S; Goldwirt L; Amorim S; Brice P; Brière J; de Kerviler E; Mourah S; Sauvageon H; Thieblemont C
    Blood; 2015 Oct; 126(14):1695-8. PubMed ID: 26239089
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Combined inhibition of Bcl-2/Bcl-xL and Usp9X/Bag3 overcomes apoptotic resistance in glioblastoma in vitro and in vivo.
    Karpel-Massler G; Shu C; Chau L; Banu M; Halatsch ME; Westhoff MA; Ramirez Y; Ross AH; Bruce JN; Canoll P; Siegelin MD
    Oncotarget; 2015 Jun; 6(16):14507-21. PubMed ID: 26008975
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Norcantharidin induces growth inhibition and apoptosis of glioma cells by blocking the Raf/MEK/ERK pathway.
    Zheng J; Du W; Song LJ; Zhang R; Sun LG; Chen FG; Wei XT
    World J Surg Oncol; 2014 Jul; 12():207. PubMed ID: 25022352
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Mouse models of mantle cell lymphoma, complex changes in gene expression and phenotype of engrafted mcl cells: implications for preclinical research.
    Klanova M; Soukup T; Jaksa R; Molinsky J; Lateckova L; Maswabi BC; Prukova D; Brezinova J; Michalova K; Vockova P; Hernandez-Ilizaliturri F; Kulvait V; Zivny J; Vokurka M; Necas E; Trneny M; Klener P
    Lab Invest; 2014 Jul; 94(7):806-17. PubMed ID: 24862967
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Downregulation of Sp1 is involved in honokiol-induced cell cycle arrest and apoptosis in human malignant pleural mesothelioma cells.
    Chae JI; Jeon YJ; Shim JH
    Oncol Rep; 2013 Jun; 29(6):2318-24. PubMed ID: 23525508
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Deltex-1 activates mitotic signaling and proliferation and increases the clonogenic and invasive potential of U373 and LN18 glioblastoma cells and correlates with patient survival.
    Huber RM; Rajski M; Sivasankaran B; Moncayo G; Hemmings BA; Merlo A
    PLoS One; 2013; 8(2):e57793. PubMed ID: 23451269
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures.
    Carra E; Barbieri F; Marubbi D; Pattarozzi A; Favoni RE; Florio T; Daga A
    Cell Cycle; 2013 Feb; 12(3):491-500. PubMed ID: 23324350
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma.
    Ek S; Dictor M; Jerkeman M; Jirström K; Borrebaeck CA
    Blood; 2008 Jan; 111(2):800-5. PubMed ID: 17934069
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement.
    Gleeson HK; Stoeter R; Ogilvy-Stuart AL; Gattamaneni HR; Brennan BM; Shalet SM
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3682-9. PubMed ID: 12915655
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy.
    Strik H; Deininger M; Streffer J; Grote E; Wickboldt J; Dichgans J; Weller M; Meyermann R
    J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):763-8. PubMed ID: 10567494
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Central nervous system involvement in patients with mantle cell lymphoma.
    Oinonen R; Franssila K; Elonen E
    Ann Hematol; 1999 Mar; 78(3):145-9. PubMed ID: 10211757
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.